Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 14/20 | 0.90 |
| ▸ | ESR1 | P03372 | 13/20 | 0.90 |
| ▸ | ABL1 | P00519 | 2/20 | 0.81 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.81 |
| ▸ | BCR | P11274 | 2/20 | 0.81 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.77 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.77 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.77 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.77 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.77 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.77 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.77 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30275026 | 1.00 | ESR2 (0.90) | ESR2ESR1ABL1ABCB1BCR | |
| SCHEMBL29991899 | 0.95 | ESR1 (1.00) | ESR2ESR1ABL1ABCB1BCR | |
| SCHEMBL2699234 | 0.95 | ESR1 (1.00) | ESR2ESR1ABL1ABCB1BCR | |
| SCHEMBL8536612 | 0.95 | ABL1 (0.82) | ESR2ESR1ABL1ABCB1BCR | |
| Methane SCHEMBL5526746 | 0.92 | ESR1 (0.95) | ESR2ESR1ABL1ABCB1BCR | |
| SCHEMBL516421 | 0.92 | ESR1 (0.90) | ESR2ESR1ABL1ABCB1BCR | |
| SCHEMBL14506125 | 0.90 | ESR2 (0.83) | ESR2ESR1ABL1ABCB1BCR | |
| SCHEMBL1741908 | 0.90 | ABL1 (1.00) | ESR2ESR1ABL1ABCB1BCR | |
| SCHEMBL21729891 | 0.90 | ESR1 (0.87) | ESR2ESR1ABL1ABCB1BCR | |
| SCHEMBL3107306 | 0.90 | ESR2 (0.83) | ESR2ESR1ABL1ABCB1BCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108291122-A | Anionic curable composition | 设计分子有限公司 | 2018-07-17 | — | — | CN | claimed |
| JP-6032893-A | — | — | None | — | — | JP | disclosed |
| JP-6025400-A | — | — | None | — | — | JP | disclosed |
| US-11069557-B2 | Method for producing thin wafer | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-07-20 | — | — | US | disclosed |
| EP-3618102-B1 | METHOD FOR PRODUCING THIN WAFER | SHINETSU CHEMICAL CO (JP) | 2021-05-19 | — | — | EP | disclosed |
| US-10886119-B2 | Aromatic underlayer | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2021-01-05 | — | — | US | disclosed |
| US-10727103-B2 | Semiconductor device, method for producing the same, and laminate | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-07-28 | — | — | US | disclosed |
| US-10658314-B2 | Wafer laminate, method for production thereof, and adhesive composition for wafer laminate | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-05-19 | — | — | US | disclosed |
| EP-3467069-B1 | SEMICONDUCTOR DEVICE, METHOD FOR PRODUCING THE SAME, AND LAMINATE | SHINETSU CHEMICAL CO (JP) | 2020-04-29 | — | — | EP | disclosed |
| US-20200075388-A1 | METHOD FOR PRODUCING THIN WAFER | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-03-05 | — | — | US | disclosed |
| US-8674138-B2 | Binaphthalene derivatives, preparation method thereof and organic electronic device using the same | LG CHEM. LTD. (KR) | 2014-03-18 | — | — | US | disclosed |
| US-20070108892-A1 | Binaphthalene derivatives, preparation method thereof and organic electronic device using the same | LG CHEM. LTD. (KR) | 2007-05-17 | — | — | US | disclosed |
| US-20070108892-A1 | Binaphthalene derivatives, preparation method thereof and organic electronic device using the same | LG CHEM. LTD. (KR) | 2007-05-17 | — | — | US | disclosed |
| WO-2007046658-A1 | NEW BINAPHTHALENE DERIVATIVES, PREPARATION METHOD THEREOF AND ORGANIC ELECTRONIC DEVICE USING THE SAME | LG CHEM. LTD. (KR) | 2007-04-26 | — | — | WO | disclosed |
| US-20070015813-A1 | Treatment of protein folding disorders | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2007-01-18 | — | — | US | disclosed |
| US-20070015813-A1 | Treatment of protein folding disorders | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2007-01-18 | — | — | US | disclosed |
| US-20070015813-A1 | Treatment of protein folding disorders | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 2007-01-18 | — | — | US | disclosed |
| US-20030092637-A1 | Novel compounds | XYLOGEN AB (SE) | 2003-05-15 | — | — | US | disclosed |
| JP-H0632893-A | AROMATIC POLYESTER AND ITS PRODUCTION | IDEMITSU KOSAN CO LTD | 1994-02-08 | — | — | JP | disclosed |
| JP-H0625400-A | POLYCARBONATE AND ITS PRODUCTION | IDEMITSU KOSAN CO LTD | 1994-02-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030092637-A1 | Novel compounds | ENTPD5, G6PD, G6PC1 | ESR2 3677/4885ESR1 4428/4885ABL1 2226/4885 |
| US-20070015813-A1 | Treatment of protein folding disorders | HSPA5, TTR, TUFM | ESR2 3195/4885ESR1 3985/4885ABL1 2275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.